DaehanPharmaceutical
대한약품 · 023910
Health Care Pharmaceuticals · KOSDAQ
Market cap US$114.6M (₩158.1B)
Overview
DaehanPharmaceutical makes intravenous fluids and ampoule-based medicines, the basic liquid drugs that hospitals and clinics use to hydrate and nourish patients who cannot take medication by mouth.
It supplies these products primarily to hospitals and clinics, while also reaching pharmacy consumers through over-the-counter items such as lens-cleaning solutions and sodium chloride wash. Listed on KOSDAQ, Korea's small-cap and technology board, the company derives the large majority of its revenue from the hospital and clinic channel, giving it a concentrated but stable customer base.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$142M
- FY2024US$148M
- FY2025US$151.2M
Operating profit
- FY2023US$25.9M
- FY2024US$27.6M
- FY2025US$22.6M
Net income
- FY2023US$20.6M
- FY2024US$24.5M
- FY2025US$20M
Key ratios (FY2025)
Why it matters
Korean pharmaceutical pricing, distribution, and advertising are subject to direct government regulation, which shapes the competitive and margin environment for all domestic drug suppliers.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?